Natixis Upgrades Novartis To Buy
Analysts at Natixis upgraded Novartis AG (NYSE: NVS) from Neutral to Buy.
Novartis shares have gained 19.21% over the past 52 weeks, while the S&P 500 index has surged 12.49% in the same period.
Novartis' shares fell 0.32% to $98.74 in pre-market trading.
Latest Ratings for NVS
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2021 | Argus Research | Downgrades | Buy | Hold |
| Feb 2021 | Cowen & Co. | Downgrades | Outperform | Market Perform |
| Jan 2021 | Deutsche Bank | Initiates Coverage On | Buy |
View More Analyst Ratings for NVS
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: NatixisUpgrades Analyst Ratings
